NCT06757270Completed
Efficacy of Aleo Vera Use in Prevention and Treatment of Chemotherapy-Induced Oral Mucositis in a Group of Egyptian Children with Acute Leukemia
Source: ClinicalTrials.gov · Last updated 3 Jan 2025
Brief summary (registry, in English)
evaluatation the efficacy of Aleovera in prevention and treatment of chemotherapy-induced oral mucositis in children suffering from acute leukemia in terms of appearance and severity
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 40 (actual)
- First submitted
- 17 Dec 2024
- Start date
- 7 Mar 2023
- Primary completion date
- 7 Mar 2024
- Lead sponsor
- Ain Shams University
- Diseases
- Childhood cancers
- NCT number
- NCT06757270
What you commit to
- Study type: Interventional
- Participants enrolled: 40
- From 7 Mar 2023 to the primary completion date, 7 Mar 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Who the study is looking for
- Patients suffering from Acute leukemia( Acute Lymphocytic Leukemia ).
- Patients scheduled for chemotherapy treatment.
- Patients who range from 3 to 13 years old.
- Patients with no history of any chemotherapy or radiotherapy. 5 -Both sexes Exclusion Criteria
- 1-Patients scheduled for radiotherapy treatment . 2-Existence of any signs or symptoms of oral mucositis. 3-Unwilling to participation in the study 4- Patients with any other systemic diseases or other neoplasms.
Age in the registry: 3 years to 13 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Faculty of dentistry Coordinator of this site? Confirm its status | Cairo | Egypt | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.